MAP1LC3A and breast carcinoma: 3-Methyladenine (3-MA), which is the most commonly used pharmacological inhibitor of autophagy that blocks the formation of autophagosomes22, decreased ARD1-induced autophagosome formation in breast cancer cells as measured by LC3 conversion in ARD1-bearing cells (Fig. 3e).